A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome^® gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise

References

• Al-Saeed, A. (2011). Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs. Oman Medical Journal, 26, 385−391. doi:10.5001/omj.2011.101
   PubMedGoogle Scholar
• Bagheri, H., Lhiaubet, V., Montastruc, J. L., & Chouini-Lalanne, N. (2000). Photosensitivity to ketoprofen: Mechanisms and pharmacoepidemiological data. Drug Safety, 22, 339–349. doi:10.2165/00002018-200022050-00002
   PubMed Web of Science ®Google Scholar
• Cevc, G., & Blume, G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1104, 226–232. doi:10.1016/0005-2736(92)90154-E
   PubMed Web of Science ®Google Scholar
• Cevc, G., & Gebauer, D. (2003). Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophysical Journal, 84, 1010–1024. doi:10.1016/S0006-3495(03)74917-0
   PubMed Web of Science ®Google Scholar
• Conaghan, P. G. (2012). A turbulent decade for NSAIDs: Update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatology International, 32, 1491−1502. doi:10.1007/s00296-011-2263-6
   PubMed Web of Science ®Google Scholar
• Conaghan, P. G., Bijlsma, J. W., Kneer, W., Wise, E., Kvien, T. K., & Rother, M. (2014). Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: A review of clinical efficacy and safety. Current Medical Research and Opinion, 30, 599−611. doi:10.1185/03007995.2013.860018
   PubMed Web of Science ®Google Scholar
• Conaghan, P. G., Dickson, J., Bolten, W., Cevc, G., & Rother, M. (2013). A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology, 52, 1303−1312. doi:10.1093/rheumatology/ket133
   Web of Science ®Google Scholar
• Elder, C. L., Dahners, L. E., & Weinhold, P. S. (2001). A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. American Journal of Sports Medicine, 29, 801−805.
   PubMed Web of Science ®Google Scholar
• Ferry, S. T., Dahners, L. E., Afshari, H. M., & Weinhold, P. S. (2007). The effects of common anti-inflammatory drugs on the healing rat patellar tendon. American Journal of Sports Medicine, 35, 1326−1333. doi:10.1177/0363546507301584
   PubMed Web of Science ®Google Scholar
• Harirforoosh, S., & Jamali, F. (2009). Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opinion on Drug Safety, 8, 669−681. doi:10.1517/14740330903311023
   PubMed Web of Science ®Google Scholar
• Heyneman, C. A., Lawless-Liday, C., & Wall, G. C. (2000). Oral versus topical NSAIDs in rheumatic diseases. Drugs, 60, 555−574. doi:10.2165/00003495-200060030-00004
   PubMed Web of Science ®Google Scholar
• Hills, B. A. (1995). Remarkable anti-wear properties of joint surfactant. Annals of Biomedical Engineering, 23, 112–115. doi:10.1007/BF02368318
   PubMed Web of Science ®Google Scholar
• Hills, B. A., & Monds, M. K. (1998). Deficiency of lubricating surfactant lining the articular surfaces of replaced hips and knees. British Journal of Rheumatology, 37, 143−147. doi:10.1093/rheumatology/37.2.143
   Google Scholar
• Klinge, S. A., & Sawyer, G. A. (2013). Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: A comprehensive review. The Physician and Sportsmedicine, 41, 64−74. doi:10.3810/psm.2013.05.2016
   PubMed Web of Science ®Google Scholar
• Kneer, W., Rother, I., Rother, M., & Seidel, E., IDEA-033-III-01 Study Group. (2009). A multiple-dose, open-label, safety, compliance, and usage evaluation study of epicutaneously applied Diractin (ketoprofen in Transfersome) in joint/musculoskeletal pain or soft tissue inflammation. Current Drug Safety, 4, 5−10. doi:10.2174/157488609787354468
   PubMedGoogle Scholar
• Kneer, W., Rother, M., Mazgareanu, S., & Seidel, E. J. European IDEA-033 study group (2013) A 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome® gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee. Journal of Pain Research, 6, 743−753.
   PubMed Web of Science ®Google Scholar
• Nieman, D. C., Henson, D. A., Dumke, C. L., Oley, K., McAnulty, S. R., Davis, J. M., … Morrow, J. D. (2006). Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain, Behavior and Immunity, 20, 578–584. doi:10.1016/j.bbi.2006.02.001
   PubMed Web of Science ®Google Scholar
• Nikanne, E., Kokki, H., Salo, J., & Linna, T. J. (2005). Celecoxib and ketoprofen for pain management during tonsillectomy: A placebo-controlled clinical trial. Otolaryngology – Head and Neck Surgery, 132, 287−294. doi:10.1016/j.otohns.2004.09.005
   PubMed Web of Science ®Google Scholar
• Rother, M., & Conaghan, P. G. (2013). A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. Journal of Rheumatology, 40, 1742−1748. doi:10.3899/jrheum.130192
   PubMed Web of Science ®Google Scholar
• Rother, M., Yeoman, G., & Ekman, E. (2012). A double-blind, placebo-controlled trial comparing the safety and efficacy of epicutaneously applied ketoprofen in Transfersome gel with naproxen for the treatment of pain associated with osteoarthritis (OA) of the knee. Poster session presented at EULAR. Berlin.
   Google Scholar
• Shen, W., Li, Y., Tang, Y., Cummins, J., & Huard, J. (2005). NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. The American Journal of Pathology, 167, 1105−1117. doi:10.1016/S0002-9440(10)61199-6
   Web of Science ®Google Scholar
• Warden, S. J. (2009). Prophylactic misuse and recommended use of non-steroidal anti-inflammatory drugs by athletes. British Journal of Sports Medicine, 43, 548−549. doi:10.1136/bjsm.2008.056697
   Web of Science ®Google Scholar
• Warden, S. J. (2010). Prophylactic use of NSAIDs by athletes: A risk/benefit assessment. The Physician and Sportsmedicine, 38, 132−138. doi:10.3810/psm.2010.04.1770
   PubMed Web of Science ®Google Scholar
• Warner, D. C., Schnepf, G., Barrett, M. S., Dian, D., & Swigonski, N. L. (2002). Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. Journal of Adolescent Health, 30, 150−153. doi:10.1016/S1054-139X(01)00325-1
   PubMed Web of Science ®Google Scholar
• Wilcox, C. M., Cryer, B., & Triadafilopoulos, G. (2005). Patterns of use and public perception of over-the-counter pain relievers: Focus on nonsteroidal antiinflammatory drugs. Journal of Rheumatology, 32, 2218−2224.
   PubMed Web of Science ®Google Scholar